Print
Email
Print Edition Stories
Boston Scientific Corp. has won a patent infringement lawsuit that Johnson & Johnson Co. brought against the Natick medical device company in 2008.
The lawsuit filed by J&J alleged that Boston Scientific infringed on J&J patents – U.S. Patents Nos. 5,516,781 and 5,563,146 – linked to a drug’s use in a drug-eluting stent with the Natick company’s Promus Everolimus-Eluting Coronary Stent System.
The U.S. District Court for the District of New Jersey ruled in favor of Boston Scientific, claiming the lawsuit by J&J to be “invalid.”
Boston Scientific (NYSE: BSX) said earlier this month that it has plans for increasing profitability through the expected launch of 24 new products in 2012. The announcement follows a statement in December in which the Internal Revenue Service said that Boston Scientific owes $581 million in back taxes plus interest and penalties – a claim that Boston Scientific disagreed with in an SEC filing.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
